Skip to main content
Signal8

VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership

$VSEEPress releaseJun 11, 2026, 8:30 AM ETRead the release

VSee Health completed the sale of its VSee Lab subsidiary to former Co-CEO Milton Chen, who in turn returned 2,870,069 shares of VSee stock to the company for retirement. The retired shares represent approximately 7% of outstanding common stock, effectively reducing dilution and simplifying the capital structure. Concurrently, Milton Chen resigned as Co-CEO and Chairman, with Dr.

Key figures

Shares retired
2870069
Shares retired pct
7%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.